(Q41341811)

29 September 2017

The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension (English)

1 reference

29 September 2017

Davey MJ

1

1 reference

PMC publication ID

1400747

29 September 2017

language of work or name

English

0 references

publication date

1 January 1986

1 reference

British Journal of Clinical Pharmacology

29 September 2017

1 reference

29 September 2017

21 Suppl 1

1 reference

29 September 2017

5S-8S

1 reference

The addition of prazosin to standard triple therapy in the treatment of severe hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart Failure

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Mini-review. The postsynaptic alpha 2-adrenoreceptor

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Review of the use of alpha-adrenoceptor antagonists in hypertension

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Prazosin and Clonidine for Moderately Severe Hypertension

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Metabolic Effects of Chronic Prazosin Treatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Prazosin in the treatment of patients with hypertension and renal functional impairment

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400747

Neurogenic factors in human hypertension: mechanism or myth?

11 June 2018

1 reference

12 December 2020

Metabolic effects of prazosin

1 reference

12 December 2020

New approaches to the therapy of mild hypertension

1 reference

12 December 2020

Effect of propranolol and prazosin on blood lipids. The Oslo Study

1 reference

12 December 2020

10.1111/J.1365-2125.1986.TB02847.X

Identifiers

DOI

1 reference

29 September 2017

1 reference

PMC publication ID

1400747

29 September 2017

PubMed publication ID

2871856

1 reference

PMC publication ID

1400747